A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma

Clinical trial NCT02706782 · UNKNOWN

Trial details

NCT number: NCT02706782
Sponsor: Shanghai GeneChem Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2016-03-01
Primary completion: 2018-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.